Navigation Links
Innovative Drug Delivery Systems Market Pharma Companies Opportunities Analyzed in a Research Report at

Dallas, Texas (PRWEB) September 29, 2013

There are more than 1400 sustained or controlled release drugs approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is approximately 20% of the overall international pharmaceutical market. Utilization of generic in terms of volume is higher in the US and lower in Japan, 89% and 24% respectively.

The oral drug delivery market remains the largest slice of the overall drug delivery market, with more than 52% of market share. It is presently valued at $49 billion and is expected to reach over $90 billion by 2016, at a CAGR of 11%. The growth in the oral drug delivery market shall be driven primarily by newer technologies enabling controlled release formulations of oral drugs and oral formulations of injectable only drugs. Global injectable drug delivery market ( is expected to be worth $29b by 2015.

Novel drug delivery systems (NDDS) offer many more advantages, which include improved therapy by increasing the efficacy and duration of drug activity, increased patient compliance through decreased dosing frequency and convenient routes of administration, and improved targeting for a specific site to reduce unwanted side effects. The challenge for both drug and drug delivery companies is to deliver both existing and emerging drug technologies in a manner that improves the current benefits enjoyed by the patients.

The generic market with reference to innovative molecule (NCE) has become very competitive as several companies have already filed ANDA's for potential generic drugs in the near term. The study of the novel drug delivery companies and their formulation technologies will provide the potential value added opportunity in the generic field in terms of patient’s compliance or bioavailability enhancement. It will also provide an enhanced life cycle for drugs under patent coverage (life cycle extension).

This comprehensive report on novel drug delivery system focuses mainly on the oral and injectable formulations of pharmaceuticals and specialty companies. This report enumerates the various formulation technologies involved in making value added formulations, pharmaceutical applications and advantages of specific technologies. Wherever possible, marketed drugs using a similar technology have been discussed as proof of validation along with the status of additional pipeline. The discussed proprietary formulation technologies includes Colal, Glide SDI, Arestat, GeoClock, GeoMatrix, FlashTab, Lock Tab, Medusa, Eligen, Oradur, EnteriCare and Saber.

This report will be helpful for those pharma companies who are exploring novel opportunities for their growth by in-licensing formulation technology or value added pipeline drugs available/being studied in the market.

Buy a copy of report @

Table of Contents:
1. Global Generic Business – Present Status and Future Opportunities
2. Therapeutic focus and Trends in Advanced drug Delivery System based on recent deals
3. Patent expiry impact and generic companies strategies –Super generics
4. The relationship between solubility and permeability in formulations
5. Formulation approach for water –insoluble drugs and oral peptide delivery
6. FDA guidelines for 505 (b)(2) applications and advantage of development
7. Types of changes allowed in 505 (b)(2) development and its advantage
8. Regulatory challenges in clinical data requirement in 505(b)(2) development and safety studies
9. Analysis, Application and Advantages of formulations technologies for more than 75 pharma companies with over 100 formulation technologies in oral and injectable formulations discussed
10. Late stage pipeline development for discussed specialty and major Pharma companies

Other Related Reports on Drug Delivery Systems Market (
Global Pulmonary Drug Delivery Systems Market 2012-2016: Analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market ( has also been witnessing an increasing adoption of online marketing strategy.

Global Nanotechnology Drug Delivery Market 2012-2016: Analysts forecast the Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market ( has also been witnessing an increase in customer support services.

Nanotechnology Drug Delivery Market in the US 2012-2016: Analysts forecast the Nanotechnology Drug Delivery market in the US to grow at a CAGR of 84.79 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R and D cost. The Nanotechnology Drug Delivery market in the US ( has also been witnessing the trend of emergence of personalized medicines. However, the increasing safety concerns could pose a challenge to the growth of this market.

About Us is an online market research reports ( library of 200,000+ reports and in-depth studies of 5000+ micro markets.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The Innovative New Methods at Drug Rehab Center Woodside are Working Well
2. U.S. Preventive Medicine Awarded Exclusive, Workplace Health Program for Innovative Self-Funded Health Benefits Plan, Health Options Plus™
3. San Francisco Health Plan’s Innovative Diabetes Text Messaging Program Expanded to Include Members Affected with Asthma
4. “Cities as a Lab” Report Spotlights How Innovative Design Strengthens Economy and Spurs Invention in Urban America
5. Introducing an Innovative New Pillow for Better Sleep and Better Back Pain Relief
6. Virtual Health Care Offers a New, Innovative Solution To Impending Health Care Shortage
7. Florida Hospital and Tampa Bay Buccaneers Announce Innovative Health Partnership
8. SmartDraw Adds Innovative Features and Lean Tools in New Release
9. IncentOne Launches Personal Choice Rewards™ Innovative New Rewards Program
10. Horizon BCBSNJ and Jersey City Medical Center to Develop Innovative, Patient-Centered Initiative to Improve Care, Lower Costs
11. Rod J. Rohrich Demonstrates Innovative Approach to Lower Eye Lifts with 5 Step Blepharoplasty Video
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is updating their ... surgeons performed their 6,000th free flap breast reconstruction surgery! , “What an accomplishment for ... excited to rebuild lives and it’s an honor to have served all of these ...
(Date:11/26/2015)... (PRWEB) , ... November 26, ... ... online platform for mental health and wellness consultation, has collaborated with Women’s ... holistically address their reader’s queries on topics on mental and emotional well-being ...
(Date:11/25/2015)... ... 25, 2015 , ... As part of a global movement ... volunteers together who want to combine talents and resources to help create sustainable ... process. The non-profit launched its first major fundraiser on November 6, 2015 at ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, one of the ... stellar workplace culture with the company’s Cincinnati office being named a finalist among ... was named a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati Best ...
(Date:11/25/2015)... ... 2015 , ... Ministers, senior government and UN agencies, representatives ... of Excellence, and public R&D institutions, civil societies and other partners gathered today ... African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- day ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... "Radioimmunoassay Market by Type (Reagents & ... Academics, Clinical Diagnostic Labs), Application (Research, Clinical ... 2020" report to their offering. ... addition of the "Radioimmunoassay Market by ...
(Date:11/25/2015)... global healthcare industry is expected to grow at a rate ... has the highest projected growth at 12.7%, and ... is second with growth projected at 11.5%. ... 2013-2014, total government funded healthcare was nearly 68%. Federal government ... 2013-2014. In real terms, out of pocket expenditure increased by ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology: